HIGH-DENSITY-LIPOPROTEIN RESPONSE TO 5-ALPHA-DIHYDROTESTOSTERONE AND TESTOSTERONE IN MACACA-FASCICULARIS - A HORMONE-RESPONSIVE PRIMATE MODEL FOR THE STUDY OF ATHEROSCLEROSIS

被引:9
作者
GREGER, NG
INSULL, W
PROBSTFIELD, JL
KEENAN, BS
机构
[1] BAYLOR UNIV, DEPT PEDIAT, HOUSTON, TX 77030 USA
[2] BAYLOR UNIV, DEPT INTERNAL MED, HOUSTON, TX 77030 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1990年 / 39卷 / 09期
关键词
D O I
10.1016/0026-0495(90)90301-R
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A decrease in high-density lipoprotein cholesterol (HDL-C), a major risk factor for coronary artery disease, occurs during puberty in males. Previous studies have shown this decrease with testosterone (T) therapy for adolescent males, but the mechanism of this effect is unknown and has not been studied in a non-human primate. Two adult male monkeys (Macaca fascicularis) were studied to determine simultaneous changes in plasma androgens and HDL-C during the phases precastration (Ci); postcastration (Cx); Cx and T therapy; Cx and dihydrotestosterone (DHT) therapy; and T and 5-α-reductase inhibitor therapy (4-MA). After castration, the HDL-C concentrations increased significantly in both animals (monkey A, 57.0 ± 1.8 mg/dL SE to 66.6 ± 2.2, P < .005; monkey B, 62.9 ± 1.6 to 80.2 ± 1.7, P < .001). T-propionate treatment produced a significant decrease in HDL-C (monkey A, 48.0 ± 5.0, P < .01; monkey B, 43.5 ± 0.5, P < .001), which was similar to HDL-C reductions seen when treated with a nonaromatizeable androgen, DHT-propionate (monkey A, 47.5 ± 1.5, P < .005; monkey B, 44.5 ± 3.5, P < .001). T and the 5-α-reductase inhibitor therapy did not increase HDL-C from the levels with T therapy alone (monkey A, 55.7 ± 1.9, NS; monkey B, 57.3 ± 0.3, NS). This study describes for the first time the features of a primate model that is potentially useful for further study of hormone-lipoprotein interactions and suggests that the reduction of HDL-C in response to testosterone can occur without further metabolism of the androgen. The benefits/side effects of therapeutic intervention with antiandrogens could be studied in such a model. © 1990.
引用
收藏
页码:919 / 924
页数:6
相关论文
共 30 条
[1]   COMBINED RADIOIMMUNOASSAY OF 4 STEROIDS IN ONE ML OF PLASMA .2. ANDROGENS [J].
ABRAHAM, GE ;
MANLIMOS, FS ;
SOLIS, M ;
WICKMAN, AC .
CLINICAL BIOCHEMISTRY, 1975, 8 (06) :374-378
[2]   INHIBITION OF TESTOSTERONE-METABOLISM IN THE BRAIN AND CLOACAL GLAND OF THE QUAIL BY SPECIFIC INHIBITORS AND ANTIHORMONES [J].
ALEXANDRE, C ;
BALTHAZART, J .
JOURNAL OF ENDOCRINOLOGY, 1987, 112 (02) :189-195
[3]   CHOLESTEROL, HIGH-DENSITY LIPOPROTEIN AND DANAZOL [J].
ALLEN, JK ;
FRASER, IS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (01) :149-152
[4]   EFFECTS OF AROMATIZATION INHIBITOR ANDROST-4-ENE-3,6,17-TRIONE ON SEXUAL DIFFERENTIATION INDUCED BY TESTOSTERONE IN NEONATALLY CASTRATED RAT [J].
BOOTH, JE .
JOURNAL OF ENDOCRINOLOGY, 1978, 79 (01) :69-76
[5]   RESPONSE OF RAT VENTRAL PROSTATE TO A NEW AND NOVEL 5ALPHA-REDUCTASE INHIBITOR [J].
BROOKS, JR ;
BAPTISTA, EM ;
BERMAN, C ;
HAM, EA ;
HICHENS, M ;
JOHNSTON, DBR ;
PRIMKA, RL ;
RASMUSSON, GH ;
REYNOLDS, GF ;
SCHMITT, SM ;
ARTH, GE .
ENDOCRINOLOGY, 1981, 109 (03) :830-836
[6]   HIGH-DENSITY LIPOPROTEINS DURING HYPOLIPIDEMIC THERAPY - COMPARATIVE-STUDY OF 4 DRUGS [J].
CHEUNG, MC ;
ALBERS, JJ ;
WAHL, PW ;
HAZZARD, WR .
ATHEROSCLEROSIS, 1980, 35 (03) :215-228
[7]   TREATMENT OF PERSISTENT PUBERTAL GYNECOMASTIA WITH DIHYDROTESTOSTERONE HEPTANOATE [J].
EBERLE, AJ ;
SPARROW, JT ;
KEENAN, BS .
JOURNAL OF PEDIATRICS, 1986, 109 (01) :144-149
[8]   INFLUENCE OF ANDROGENS, ESTROGENS AND RELATED STEROIDS ON SERUM LIPIDS AND LIPOPROTEINS - OBSERVATIONS IN HYPOGONADAL AND NORMAL HUMAN SUBJECTS [J].
FURMAN, RH ;
HOWARD, RP ;
NORCIA, LN ;
KEATY, EC .
AMERICAN JOURNAL OF MEDICINE, 1958, 24 (01) :80-97
[9]   SUPPRESSION OF PLASMA TESTOSTERONE LEADS TO AN INCREASE IN SERUM TOTAL AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND APOPROTEIN-A-I AND APOPROTEIN-B [J].
GOLDBERG, RB ;
RABIN, D ;
ALEXANDER, AN ;
DOELLE, GC ;
GETZ, GS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (01) :203-207
[10]   HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714